Journal of Obesity & Metabolic Syndrome

Korean Society for the Study of Obesity (대한비만학회)
권호 표지
DOI QR코드

DOI QR Code

Vitamin D and Metabolic Diseases: Growing Roles of Vitamin D

  • Park, Jung Eun (Department of Food Science and Human Nutrition, Chonbuk National University) ;
  • Pichiah, Tirupathi (Department of Food Science and Human Nutrition, Chonbuk National University) ;
  • Cha, Youn-Soo (Department of Food Science and Human Nutrition, Chonbuk National University)
  • Received : 2018.10.22
  • Accepted : 2018.12.01
  • Published : 2018.12.30
⟨ Previous Next ⟩

Abstract

Vitamin D, a free sunshine vitamin available for mankind from nature, is capable to avert many health-related critical circumstances. Vitamin D is no more regarded as a nutrient involved in bone metabolism alone. The presence of vitamin D receptor in a number of tissues implies that vitamin D has various physiological roles apart from calcium and phosphorus metabolism. Low serum vitamin D has been found to be associated with various types of metabolic illness such as obesity, diabetes mellitus, insulin resistance, cardiovascular diseases including hypertension. Various studies reported that vitamin D insufficiency or deficiency in linked with metabolic syndrome risk. This review focuses on various metabolic diseases and its relationship with serum vitamin D status.

Keywords

References

  1. Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci 2014;11:1185-200. https://doi.org/10.7150/ijms.10001
  2. O'Gorman C, Lucas R, Taylor B. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 2012;13:11718-52. https://doi.org/10.3390/ijms130911718
  3. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005;28:2926-32. https://doi.org/10.2337/diacare.28.12.2926
  4. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-30. https://doi.org/10.2337/diacare.28.5.1228
  5. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19:73-8. https://doi.org/10.1016/j.annepidem.2007.12.001
  6. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011;12:4-18. https://doi.org/10.2174/138945011793591635
  7. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007;26:573-80. https://doi.org/10.1016/j.clnu.2007.05.009
  8. Greene-Finestone LS, Garriguet D, Brooks S, Langlois K, Whiting SJ. Overweight and obesity are associated with lower vitamin D status in Canadian children and adolescents. Paediatr Child Health 2017;22:438-44. https://doi.org/10.1093/pch/pxx116
  9. Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 2013;14:393-404. https://doi.org/10.1111/obr.12016
  10. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013;10:e1001383. https://doi.org/10.1371/journal.pmed.1001383
  11. Rodriguez-Rodriguez E, Navia B, Lopez-Sobaler AM, Ortega RM. Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity (Silver Spring) 2009;17:778-82. https://doi.org/10.1038/oby.2008.649
  12. Daniel D, Hardigan P, Bray N, Penzell D, Savu C. The incidence of vitamin D deficiency in the obese: a retrospective chart review. J Community Hosp Intern Med Perspect 2015;5:26069. https://doi.org/10.3402/jchimp.v5.26069
  13. Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 2015;16:341-9. https://doi.org/10.1111/obr.12239
  14. Wong KE, Kong J, Zhang W, Szeto FL, Ye H, Deb DK, et al. Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. J Biol Chem 2011;286:33804-10. https://doi.org/10.1074/jbc.M111.257568
  15. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 2009;124:e362-70. https://doi.org/10.1542/peds.2009-0051
  16. Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK, et al. 1Alpha,25-dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 2008;112:122-6. https://doi.org/10.1016/j.jsbmb.2008.09.006
  17. Ishida Y, Taniguchi H, Baba S. Possible involvement of 1 alpha,25-dihydroxyvitamin D3 in proliferation and differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 1988;151:1122-7. https://doi.org/10.1016/S0006-291X(88)80482-0
  18. Sato M, Hiragun A. Demonstration of 1 alpha,25-dihydroxyvitamin D3 receptor-like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation. J Cell Physiol 1988;135:545-50. https://doi.org/10.1002/jcp.1041350326
  19. Wood RJ. Vitamin D and adipogenesis: new molecular insights. Nutr Rev 2008;66:40-6. https://doi.org/10.1111/j.1753-4887.2007.00004.x
  20. Zhuang H, Lin Y, Yang G. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of porcine preadipocyte in vitro. Chem Biol Interact 2007;170:114-23. https://doi.org/10.1016/j.cbi.2007.07.012
  21. Veeman MT, Axelrod JD, Moon RT. A second canon: functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003;5:367-77. https://doi.org/10.1016/S1534-5807(03)00266-1
  22. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998;14:59-88. https://doi.org/10.1146/annurev.cellbio.14.1.59
  23. Duque G, Macoritto M, Kremer R. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). Exp Gerontol 2004;39:333-8. https://doi.org/10.1016/j.exger.2003.11.008
  24. Basoli V, Santaniello S, Cruciani S, Ginesu GC, Cossu ML, Delitala AP, et al. Melatonin and vitamin D interfere with the adipogenic fate of adipose-derived stem cells. Int J Mol Sci 2017;18:E981. https://doi.org/10.3390/ijms18050981
  25. Chang E, Kim Y. Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes. Nutrition 2016;32:702-8. https://doi.org/10.1016/j.nut.2015.12.032
  26. Ricciardi CJ, Bae J, Esposito D, Komarnytsky S, Hu P, Chen J, et al. 1,25-Dihydroxyvitamin D3/vitamin D receptor suppresses brown adipocyte differentiation and mitochondrial respiration. Eur J Nutr 2015;54:1001-12. https://doi.org/10.1007/s00394-014-0778-9
  27. Sakuma S, Fujisawa J, Sumida M, Tanigawa M, Inoda R, Sujihera T, et al. The involvement of mitogen-activated protein kinases in the $1{\alpha}$,25-dihydroxy-cholecalciferol-induced inhibition of adipocyte differentiation in vitro. J Nutr Sci Vitaminol (Tokyo) 2012;58:1-8. https://doi.org/10.3177/jnsv.58.1
  28. Sun X, Zemel MB. 1Alpha, 25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor. Int J Obes (Lond) 2008;32:1305-11. https://doi.org/10.1038/ijo.2008.59
  29. Cianferotti L, Demay MB. VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J Cell Biochem 2007;101:80-8. https://doi.org/10.1002/jcb.21151
  30. Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006;290:E916-24. https://doi.org/10.1152/ajpendo.00410.2005
  31. Huang Y, Ishizuka T, Miura A, Kajita K, Ishizawa M, Kimura M, et al. Effect of 1 alpha,25-dihydroxy vitamin D3 and vitamin E on insulin-induced glucose uptake in rat adipocytes. Diabetes Res Clin Pract 2002;55:175-83. https://doi.org/10.1016/S0168-8227(01)00324-2
  32. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB. 1Alpha,25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J 2002;16:1808-10. https://doi.org/10.1096/fj.02-0255fje
  33. Kelly KA, Gimble JM. 1,25-Dihydroxy vitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 1998;139:2622-8. https://doi.org/10.1210/endo.139.5.5970
  34. Raederstorff D. Antioxidant activity of olive polyphenols in humans: a review. Int J Vitam Nutr Res 2009;79:152-65. https://doi.org/10.1024/0300-9831.79.3.152
  35. Zhu W, Cai D, Wang Y, Lin N, Hu Q, Qi Y, et al. Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: a randomized controlled trial. Nutr J 2013;12:8. https://doi.org/10.1186/1475-2891-12-8
  36. Sergeev IN, Song Q. High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apoptosis. Mol Nutr Food Res 2014;58:1342-8. https://doi.org/10.1002/mnfr.201300503
  37. Ping-Delfos WC, Soares M. Diet induced thermogenesis, fat oxidation and food intake following sequential meals: influence of calcium and vitamin D. Clin Nutr 2011;30:376-83. https://doi.org/10.1016/j.clnu.2010.11.006
  38. Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z, et al. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 2009;296:E820-8. https://doi.org/10.1152/ajpendo.90763.2008
  39. Muscogiuri G, Annweiler C, Duval G, Karras S, Tirabassi G, Salvio G, et al. Vitamin D and cardiovascular disease: from atherosclerosis to myocardial infarction and stroke. Int J Cardiol 2017;230:577-84. https://doi.org/10.1016/j.ijcard.2016.12.053
  40. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, et al. 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-98. https://doi.org/10.1161/CIRCULATIONAHA.109.856070
  41. Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010;95:1076-83. https://doi.org/10.1210/jc.2009-1797
  42. Kang YH, Jin JS, Yi DW, Son SM. Bone morphogenetic protein-7 inhibits vascular calcification induced by high vitamin D in mice. Tohoku J Exp Med 2010;221:299-307. https://doi.org/10.1620/tjem.221.299
  43. Tang FT, Chen SR, Wu XQ, Wang TQ, Chen JW, Li J, et al. Hypercholesterolemia accelerates vascular calcification induced by excessive vitamin D via oxidative stress. Calcif Tissue Int 2006;79:326-39. https://doi.org/10.1007/s00223-006-0004-8
  44. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004;89-90:387-92. https://doi.org/10.1016/j.jsbmb.2004.03.004
  45. Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 2008;52:847-55. https://doi.org/10.1161/HYPERTENSIONAHA.108.114991
  46. Judd SE, Raiser SN, Kumari M, Tangpricha V. 1,25-Dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study. J Steroid Biochem Mol Biol 2010;121:445-7. https://doi.org/10.1016/j.jsbmb.2010.04.013
  47. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010;55:1283-8. https://doi.org/10.1161/HYPERTENSIONAHA.109.148619
  48. Weishaar RE, Kim SN, Saunders DE, Simpson RU. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol 1990;258(1 Pt 1):E134-42.
  49. Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH, et al. Effect of paricalcitol on left ventricular mass and function in CKD: the OPERA trial. J Am Soc Nephrol 2014;25:175-86. https://doi.org/10.1681/ASN.2013010103
  50. Weishaar RE, Simpson RU. The involvement of the endocrine system in regulating cardiovascular function: emphasis on vitamin D3. Endocr Rev 1989;10:351-65. https://doi.org/10.1210/edrv-10-3-351
  51. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73. https://doi.org/10.4065/81.3.353
  52. Faeh D, Gutzwiller F, Bopp M; Swiss National Cohort Study Group. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation 2009;120:495-501. https://doi.org/10.1161/CIRCULATIONAHA.108.819250
  53. Fabsitz R, Feinleib M. Geographic patterns in county mortality rates from cardiovascular diseases. Am J Epidemiol 1980;111:315-28. https://doi.org/10.1093/oxfordjournals.aje.a112903
  54. Regidor E, Reques L, Giraldez-Garcia C, Miqueleiz E, Santos JM, Martinez D, et al. The association of geographic coordinates with mortality in people with lower and higher education and with mortality inequalities in Spain. PLoS One 2015;10:e0133765. https://doi.org/10.1371/journal.pone.0133765
  55. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005;94:483-92. https://doi.org/10.1079/BJN20051544
  56. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11. https://doi.org/10.1161/CIRCULATIONAHA.107.706127
  57. Carthy EP, Yamashita W, Hsu A, Ooi BS. 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 1989;13(6 Pt 2):954-9. https://doi.org/10.1161/01.HYP.13.6.954
  58. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, et al. 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005;111:1666-71. https://doi.org/10.1161/01.CIR.0000160353.27927.70
  59. Kim JK, Park MJ, Song YR, Kim HJ, Kim SG. Vitamin D: a possible modifying factor linking obesity to vascular calcification in hemodialysis patients. Nutr Metab (Lond) 2017;14:27. https://doi.org/10.1186/s12986-017-0181-7
  60. Banerjee A, Khemka VK, Roy D, Dhar A, Sinha Roy TK, Biswas A, et al. Role of pro-inflammatory cytokines and vitamin d in probable Alzheimer's disease with depression. Aging Dis 2017;8:267-76. https://doi.org/10.14336/AD.2016.1017
  61. Jean G, Vanel T, Terrat JC, Chazot C. Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. Hemodial Int 2010;14:486-91. https://doi.org/10.1111/j.1542-4758.2010.00472.x
  62. Al-Dujaili EA, Munir N, Iniesta RR. Effect of vitamin D supplementation on cardiovascular disease risk factors and exercise performance in healthy participants: a randomized placebo-controlled preliminary study. Ther Adv Endocrinol Metab 2016;7:153-65. https://doi.org/10.1177/2042018816653357
  63. Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, Huang Y, et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 2011;24:557-62. https://doi.org/10.1038/ajh.2011.12
  64. Vimaleswaran KS, Cavadino A, Berry DJ; LifeLines Cohort Study investigators, Jorde R, Dieffenbach AK, et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2014;2:719-29. https://doi.org/10.1016/S2213-8587(14)70113-5
  65. Schottker B, Brenner H. Vitamin D as a resilience factor, helpful for survival of potentially fatal conditions: a hypothesis emerging from recent findings of the ESTHER cohort study and the CHANCES consortium. Nutrients 2015;7:3264-78. https://doi.org/10.3390/nu7053264
  66. Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol 2013;4:46-57. https://doi.org/10.5897/JPAP2013.0001
  67. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000;106:453-8. https://doi.org/10.1172/JCI10762
  68. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004;59:207-23. https://doi.org/10.1210/rp.59.1.207
  69. Apperloo EM, Pena MJ, de Zeeuw D, Denig P, Heerspink HJ. Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: a primary care cohort study. Diabetes Obes Metab 2018;20:1377-83. https://doi.org/10.1111/dom.13226
  70. Sarafidis PA, Bakris GL. Renin-angiotensin blockade and kidney disease. Lancet 2008;372:511-2. https://doi.org/10.1016/S0140-6736(08)61212-X
  71. Kobayashi H, Tokudome G, Hara Y, Sugano N, Endo S, Suetsugu Y, et al. Insulin resistance is a risk factor for the progression of chronic kidney disease. Clin Nephrol 2009;71:643-51. https://doi.org/10.5414/CNP71643
  72. Martin T, Campbell RK. Vitamin D and diabetes. Diabetes Spectr 2011;24:113-8. https://doi.org/10.2337/diaspect.24.2.113
  73. Gagnon C, Daly RM, Carpentier A, Lu ZX, Shore-Lorenti C, Sikaris K, et al. Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and ${\beta}$-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS One 2014;9:e109607. https://doi.org/10.1371/journal.pone.0109607
  74. Gao Y, Wu X, Fu Q, Li Y, Yang T, Tang W. The relationship between serum 25-hydroxy vitamin D and insulin sensitivity and ${\beta}$-cell function in newly diagnosed type 2 diabetes. J Diabetes Res 2015;2015:636891.
  75. Park S, Kim DS, Kang S. Vitamin D deficiency impairs glucosestimulated insulin secretion and increases insulin resistance by reducing PPAR-${\gamma}$ expression in nonobese Type 2 diabetic rats. J Nutr Biochem 2016;27:257-65. https://doi.org/10.1016/j.jnutbio.2015.09.013
  76. Taylor AV, Wise PH. Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J 1998;74:365-6. https://doi.org/10.1136/pgmj.74.872.365
  77. Schwalfenberg G. Vitamin D and diabetes: improvement of glycemic control with vitamin D3 repletion. Can Fam Physician 2008;54:864-6.
  78. Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxy vitamin D and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 2010;33:1373-5. https://doi.org/10.2337/dc09-2199
  79. He S, Yu S, Zhou Z, Wang C, Wu Y, Li W. Effect of vitamin D supplementation on fasting plasma glucose, insulin resistance and prevention of type 2 diabetes mellitus in non-diabetics: a systematic review and meta-analysis. Biomed Rep 2018;8:475-84.
  80. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington (DC): The National Academies Press; 2010.
  81. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81. https://doi.org/10.1056/NEJMra070553
  82. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28. https://doi.org/10.1093/ajcn/84.1.18
  83. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805-6.
  84. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-83. https://doi.org/10.1056/NEJM199803193381201
  85. Vanstone MB, Oberfield SE, Shader L, Ardeshirpour L, Carpenter TO. Hypercalcemia in children receiving pharmacologic doses of vitamin D. Pediatrics 2012;129:e1060-3. https://doi.org/10.1542/peds.2011-1663
  86. Cesur Y, Caksen H, Gundem A, Kirimi E, Odabas D. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets. J Pediatr Endocrinol Metab 2003;16:1105-9.
  87. Zeghoud F, Ben-Mekhbi H, Djeghri N, Garabedian M. Vitamin D prophylaxis during infancy: comparison of the longterm effects of three intermittent doses (15, 5, or 2.5 mg) on 25-hydroxyvitamin D concentrations. Am J Clin Nutr 1994;60:393-6. https://doi.org/10.1093/ajcn/60.3.393
  88. Pietras SM, Obayan BK, Cai MH, Holick MF. Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med 2009;169:1806-8.
  89. Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One 2014;9:e111265. https://doi.org/10.1371/journal.pone.0111265

Cited by

  1. Association between High-Density Lipoprotein Cholesterol and Vitamin D Levels in Adult Men in the Fifth Korea National Health and Nutrition Examination Survey vol.19, pp.4, 2018, https://doi.org/10.15384/kjhp.2019.19.4.210
  2. A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO) vol.11, pp.6, 2019, https://doi.org/10.3390/nu11061310
  3. Deciphering GRINA/Lifeguard1: Nuclear Location, Ca2+ Homeostasis and Vesicle Transport vol.20, pp.16, 2018, https://doi.org/10.3390/ijms20164005
  4. Serum vitamin D concentrations are inversely related to prevalence of metabolic syndrome in Qatari women vol.46, pp.1, 2018, https://doi.org/10.1002/biof.1572
  5. Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle vol.11, pp.None, 2018, https://doi.org/10.3389/fendo.2020.582870
  6. Vitamin D Supplementation Ameliorates Severity of Major Depressive Disorder vol.70, pp.2, 2018, https://doi.org/10.1007/s12031-019-01461-2
  7. Efficacy of Vitamin D 3 Buccal Spray Supplementation Compared to Other Delivery Methods: A Systematic Review of Superiority Randomized Controlled Trials vol.12, pp.3, 2018, https://doi.org/10.3390/nu12030691
  8. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders vol.21, pp.18, 2020, https://doi.org/10.3390/ijms21186644
  9. Association Between Visceral Adipose Tissue and Estradiol with Bone Health among Obese Women with Metabolic Syndrome vol.23, pp.10, 2018, https://doi.org/10.3923/pjbs.2020.1237.1244
  10. Obesity-induced Vitamin D Deficiency Contributes to Lung Fibrosis and Airway Hyperresponsiveness vol.64, pp.3, 2021, https://doi.org/10.1165/rcmb.2020-0086oc
  11. Role of Vitamin D in the Metabolic Syndrome vol.13, pp.3, 2021, https://doi.org/10.3390/nu13030830
  12. Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: role of AMPK/SIRT1 activation and DPP-4 inhibition vol.99, pp.6, 2018, https://doi.org/10.1139/cjpp-2020-0435
  13. Vitamin D Knowledge, Attitudes and Practices of Polish Medical Doctors vol.13, pp.7, 2018, https://doi.org/10.3390/nu13072443
  14. Molecular mechanisms from insulin-mimetic effect of vitamin D: treatment alternative in Type 2 diabetes mellitus vol.12, pp.15, 2021, https://doi.org/10.1039/d0fo03230a
  15. Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice vol.13, pp.10, 2021, https://doi.org/10.3390/nu13103491
  16. Differences in Fat-Free Mass According to Serum Vitamin D Level and Calcium Intake: Korea National Health and Nutrition Examination Survey 2008-2011 vol.10, pp.22, 2018, https://doi.org/10.3390/jcm10225428
  17. Association between Vitamin D Status and Carotid Atherosclerosis in Korean Adults vol.11, pp.6, 2018, https://doi.org/10.21215/kjfp.2021.11.6.464
  18. Asthma Phenotype with Metabolic Dysfunction vol.63, pp.1, 2018, https://doi.org/10.3349/ymj.2022.63.1.1